Companies / Aclaris Therapeutics, Inc. / Activity
Activity — Aclaris Therapeutics, Inc.
7 moves.
Top impactInsider · CEO movesInsider · biggest buysInsider · biggest sellsInstitution · biggest movesInstitution · new positions
| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Q1 2026 as of | RA Capital Management, L.P. 13F manager | New | Common stock | $25.52M | +6.8M | 6,804,072 4.62% of shares | medium |
| Q1 2026 as of | Balyasny Asset Management L.P. 13F manager | New | Common stock | $12.60M | +3.4M | 3,361,328 2.28% of shares | medium |
| Q4 2025 as of | Persistent Asset Partners Ltd 13F manager | New | Common stock | $67.0K | +22K | 22,259 0.02% of shares | low |
| Q1 2026 as of | Hudson Bay Capital Management LP 13F manager | New | Common stock | $63.1K | +17K | 16,820 0.01% of shares | low |
| Q1 2026 as of | Prudential Financial Inc 13F manager | New | Common stock | $50.2K | +13K | 13,380 <0.01% of shares | low |
| Q1 2026 as of | Zurcher Kantonalbank (Zurich Cantonalbank) 13F manager | New | Common stock | $18.8K | +5K | 5,006 <0.01% of shares | low |
| Q1 2026 as of | MAI Capital Management 13F manager | New | Common stock | $4 | +1 | 1 <0.01% of shares | low |